Using Iterative RE-AIM to enhance hospitalist adoption of lung ultrasound in the management of patients with COVID-19: an implementation pilot study
Background Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this s...
Uloženo v:
| Vydáno v: | Implementation science communications Ročník 3; číslo 1; s. 89 - 14 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
12.08.2022
Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 2662-2211, 2662-2211 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies.
Methods
In an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel “RE-AIM dashboard,” we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation.
Results
Over the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach.
Conclusions
Mandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. |
|---|---|
| AbstractList | Abstract Background Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies. Methods In an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel “RE-AIM dashboard,” we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation. Results Over the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach. Conclusions Mandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies.BACKGROUNDLung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies.In an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel "RE-AIM dashboard," we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation.METHODSIn an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel "RE-AIM dashboard," we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation.Over the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach.RESULTSOver the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach.Mandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings.CONCLUSIONSMandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies. In an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel "RE-AIM dashboard," we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation. Over the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach. Mandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. Background Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies. Methods In an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel “RE-AIM dashboard,” we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation. Results Over the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach. Conclusions Mandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. BackgroundLung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple disease processes, including COVID-19. Despite these advantages, few hospitalists have been trained to perform LUS. The aim of this study was to increase adoption and implementation of LUS during the 2020 COVID-19 pandemic by using recurrent assessments of RE-AIM outcomes to iteratively revise our implementation strategies.MethodsIn an academic hospital, we implemented guidelines for the use of LUS in patients with COVID-19 in July 2020. Using a novel “RE-AIM dashboard,” we used an iterative process of evaluating the high-priority outcomes of Reach, Adoption, and Implementation at twice monthly intervals to inform revisions of our implementation strategies for LUS delivery (i.e., Iterative RE-AIM process). Using a convergent mixed methods design, we integrated quantitative RE-AIM outcomes with qualitative hospitalist interview data to understand the dynamic determinants of LUS Reach, Adoption, and Implementation.ResultsOver the 1-year study period, 453 LUSs were performed in 298 of 12,567 eligible inpatients with COVID-19 (Reach = 2%). These 453 LUS were ordered by 43 out of 86 eligible hospitalists (LUS order adoption = 50%). However, the LUSs were performed/supervised by only 8 of these 86 hospitalists, 4 of whom were required to complete LUS credentialing as members of the hospitalist procedure service (proceduralist adoption 75% vs 1.2% non-procedural hospitalists adoption). Qualitative and quantitative data obtained to evaluate this Iterative RE-AIM process led to the deployment of six sequential implementation strategies and 3 key findings including (1) there were COVID-19-specific barriers to LUS adoption, (2) hospitalists were more willing to learn to make clinical decisions using LUS images than obtain the images themselves, and (3) mandating the credentialing of a strategically selected sub-group may be a successful strategy for improving Reach.ConclusionsMandating use of a strategically selected subset of clinicians may be an effective strategy for improving Reach of LUS. Additionally, use of Iterative RE-AIM allowed for timely adjustments to implementation strategies, facilitating higher levels of LUS Adoption and Reach. Future studies should explore the replicability of these preliminary findings. |
| ArticleNumber | 89 |
| Author | Ytell, Kate Fleshner, Michelle Huebschmann, Amy G. Morris, Megan A. Ho, P. Michael Kramer, Henry R. Glasgow, Russell E. Barnard, Juliana Gardner, Tiffany Maw, Anna M. Ortiz-Lopez, Carolina Grimm, Eric |
| Author_xml | – sequence: 1 givenname: Anna M. orcidid: 0000-0002-2829-7331 surname: Maw fullname: Maw, Anna M. email: anna.maw@cuanschutz.edu organization: Division of Hospital Medicine, University of Colorado School of Medicine – sequence: 2 givenname: Megan A. surname: Morris fullname: Morris, Megan A. organization: Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine – sequence: 3 givenname: Russell E. surname: Glasgow fullname: Glasgow, Russell E. organization: Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine – sequence: 4 givenname: Juliana surname: Barnard fullname: Barnard, Juliana organization: Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine – sequence: 5 givenname: P. Michael surname: Ho fullname: Ho, P. Michael organization: Division of Cardiology, University of Colorado School of Medicine – sequence: 6 givenname: Carolina surname: Ortiz-Lopez fullname: Ortiz-Lopez, Carolina organization: Division of Hospital Medicine, University of Colorado School of Medicine – sequence: 7 givenname: Michelle surname: Fleshner fullname: Fleshner, Michelle organization: Division of Hospital Medicine, University of Colorado School of Medicine – sequence: 8 givenname: Henry R. surname: Kramer fullname: Kramer, Henry R. organization: Division of Hospital Medicine, University of Colorado School of Medicine – sequence: 9 givenname: Eric surname: Grimm fullname: Grimm, Eric organization: Division of Hospital Medicine, University of Colorado School of Medicine – sequence: 10 givenname: Kate surname: Ytell fullname: Ytell, Kate organization: Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine – sequence: 11 givenname: Tiffany surname: Gardner fullname: Gardner, Tiffany organization: Internal Medicine Residency Program, University of Colorado School of Medicine – sequence: 12 givenname: Amy G. surname: Huebschmann fullname: Huebschmann, Amy G. organization: Division of General Internal Medicine, University of Colorado School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35962441$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks1u1DAUhSNUREvpC7BAlth0E_BfEocFUjUUiFRUCRW2lu04Mx45drCd0r4HD4w7aaHtoitf2ed8Pva9L4s9550uitcIvkOI1e8jJbBiJcS4hJAQWl49Kw5wXeMSY4T27tX7xVGMWwghrhCikL4o9knV1phSdFD8-RGNW4Mu6SCSudTg-2l50n0DyQPtNsIpDTY-TiYJa2ICovdTMt4BPwA7Z-NsUxDRz64HxoG00WAUTqz1qF26EU2ZmssIfpu0Aavzn92nErUfgHDAjJPd6cSOOBnrE4hp7q9fFc8HYaM-ul0Pi4vPpxerr-XZ-ZdudXJWqho2qWypaBDBmlatZoKhYZCYVIwhVvVQVTWtKGrrHtVSSoVb2RAqG1kPbMCylYocFt2C7b3Y8imYUYRr7oXhuw0f1lyEZJTVXDGte0nqmjFGUT8wzCTqkYS0oQorklkfF9Y0y1H3Kj8rCPsA-vDEmQ1f-0vekga3uMqA41tA8L9mHRMfTVTaWuG0nyPHDcSoyfeyLH37SLr1c3D5pzhmFWwww6TJqjf3E_2Lctf7LGCLQAUfY9ADV2bpRQ5oLEeQ30waXyaN50nju0njV9mKH1nv6E-ayGKKWezWOvyP_YTrL2gN50k |
| CitedBy_id | crossref_primary_10_1007_s43477_024_00134_6 crossref_primary_10_1016_j_ejim_2024_09_013 crossref_primary_10_1093_tbm_ibad078 crossref_primary_10_7759_cureus_69796 crossref_primary_10_1002_jhm_13139 crossref_primary_10_2196_55472 crossref_primary_10_1146_annurev_publhealth_071321_041652 crossref_primary_10_1177_26334895251367470 crossref_primary_10_2196_73189 crossref_primary_10_1186_s13012_024_01346_y crossref_primary_10_1186_s43058_025_00754_5 crossref_primary_10_1007_s11606_023_08580_y |
| Cites_doi | 10.3389/fpubh.2020.00194 10.3389/fpubh.2019.00064 10.1186/cc13016 10.4135/9781483384436 10.1186/s13012-019-0898-y 10.1186/1748-5908-6-42 10.1001/jamanetworkopen.2019.0703 10.1186/s13012-020-01021-y 10.3389/fpubh.2020.00134 10.1186/s40359-015-0089-9 10.1186/s13012-015-0209-1 10.1136/bmjopen-2019-033208 10.3390/diagnostics11081451 10.3389/fpubh.2018.00102 10.1590/S1516-31802010000200009 10.1016/j.ahj.2020.06.003 10.1016/j.jacc.2020.11.022 10.1097/MLR.0000000000000077 10.1186/s13613-020-00799-w 10.1136/heartjnl-2019-316429 10.1186/s13012-021-01105-3 10.1183/13993003.01519-2020 10.1002/emp2.12575 10.1007/s11606-018-4818-7 10.1016/j.amjmed.2020.03.041 10.1370/afm.1688 10.1093/intqhc/mzab106 10.1186/2001-1326-2-10 10.4300/JGME-D-20-00216.1 10.1136/bmjqs-2013-001862 10.1002/ejhf.1604 10.1371/journal.pone.0130066 10.1186/s13012-014-0165-1 10.3390/diagnostics11071172 10.1007/s43477-022-00045-4 10.1007/s00134-012-2513-4 10.3389/fpubh.2018.00071 10.3390/jcm10214818 10.7326/M20-7844 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s43058-022-00334-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 2662-2211 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_c8eedb36688841df828b1d1b0474c2c3 PMC9372925 35962441 10_1186_s43058_022_00334_x |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: National Heart, Lung, and Blood Institute grantid: K12 HL137862 funderid: http://dx.doi.org/10.13039/100000050 – fundername: National Institutes of Health grantid: UL1 TR002535 funderid: http://dx.doi.org/10.13039/100000002 – fundername: NIH HHS grantid: UL1 TR002535 – fundername: NHLBI NIH HHS grantid: K12 HL137862 – fundername: NCATS NIH HHS grantid: UL1 TR002535 – fundername: ; grantid: K12 HL137862 – fundername: ; grantid: UL1 TR002535 |
| GroupedDBID | 0R~ 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABUWG ADBBV ADUKV AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS BENPR BFQNJ BMC C6C CCPQU EBLON EBS EJD FYUFA GROUPED_DOAJ HMCUK IAO IGS ITC M~E OK1 PGMZT PHGZM PHGZT PIMPY PUEGO ROL RPM RSV SOJ UKHRP AAYXX AFFHD CITATION ALIPV NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-94a7132e459e8a81ffb23588185d0c56454196d16bbbc29b734b7b6f8f2b9bc3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 15 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001255614700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2662-2211 |
| IngestDate | Tue Oct 14 19:02:36 EDT 2025 Tue Nov 04 01:32:28 EST 2025 Fri Sep 05 07:25:24 EDT 2025 Sat Oct 18 22:46:32 EDT 2025 Mon Jul 21 05:47:47 EDT 2025 Tue Nov 18 22:05:14 EST 2025 Sat Nov 29 02:10:08 EST 2025 Sat Sep 06 07:29:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | COVID-19 Lung ultrasound RE-AIM Implementation science |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-94a7132e459e8a81ffb23588185d0c56454196d16bbbc29b734b7b6f8f2b9bc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2829-7331 |
| OpenAccessLink | https://link.springer.com/10.1186/s43058-022-00334-x |
| PMID | 35962441 |
| PQID | 2850728237 |
| PQPubID | 5068529 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c8eedb36688841df828b1d1b0474c2c3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9372925 proquest_miscellaneous_2702178288 proquest_journals_2850728237 pubmed_primary_35962441 crossref_citationtrail_10_1186_s43058_022_00334_x crossref_primary_10_1186_s43058_022_00334_x springer_journals_10_1186_s43058_022_00334_x |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-12 |
| PublicationDateYYYYMMDD | 2022-08-12 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Implementation science communications |
| PublicationTitleAbbrev | Implement Sci Commun |
| PublicationTitleAlternate | Implement Sci Commun |
| PublicationYear | 2022 |
| Publisher | BioMed Central Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: Springer Nature B.V – name: BMC |
| References | M Rivas-Lasarte (334_CR8) 2019; 21 AM Maw (334_CR25) 2021; 11 BA Rabin (334_CR28) 2018; 6 SS McMillan (334_CR40) 2016; 38 X Ye (334_CR2) 2015; 10 R Randell (334_CR24) 2020; 10 LK Leykum (334_CR32) 2014; 9 GN Guest (334_CR30) 2012 CB Laursen (334_CR11) 2021; 57 BJ Powell (334_CR23) 2015; 10 AM Maw (334_CR1) 2020; 12 MJ Taylor (334_CR41) 2014; 23 MS Bauer (334_CR13) 2015; 3 WT Riley (334_CR16) 2013; 2 C Marini (334_CR6) 2020; 106 CJ Peek (334_CR15) 2014; 12 MA Kirk (334_CR29) 2020; 15 J Torres-Macho (334_CR36) 2021; 10 M Chardoli (334_CR35) 2021; 2 D Araiza-Garaygordobil (334_CR7) 2020; 227 E Proctor (334_CR14) 2022; 2 SM Harden (334_CR19) 2018; 6 RE Glasgow (334_CR18) 2019; 7 G Volpicelli (334_CR22) 2012; 38 RC Shelton (334_CR26) 2020; 8 AM Maw (334_CR33) 2021; 11 S Michie (334_CR38) 2011; 6 S Wiltsey Stirman (334_CR27) 2019; 14 J Dyson (334_CR39) 2021; 33 334_CR21 ZA Yetmar (334_CR12) 2020; 133 RE Glasgow (334_CR17) 2020; 8 CJ Miller (334_CR37) 2021; 16 S Alrajab (334_CR5) 2013; 17 A Qaseem (334_CR9) 2021; 174 ML McCrum (334_CR31) 2014; 52 A Grimberg (334_CR3) 2010; 128 M Perez Jolles (334_CR20) 2019; 34 AM Maw (334_CR4) 2019; 2 C Writing (334_CR10) 2021; 77 JCG de Alencar (334_CR34) 2021; 11 |
| References_xml | – volume: 8 start-page: 194 year: 2020 ident: 334_CR17 publication-title: Front Public Health. doi: 10.3389/fpubh.2020.00194 – volume: 7 start-page: 64 year: 2019 ident: 334_CR18 publication-title: Front Public Health. doi: 10.3389/fpubh.2019.00064 – volume: 17 start-page: R208 issue: 5 year: 2013 ident: 334_CR5 publication-title: Crit Care. doi: 10.1186/cc13016 – volume-title: Applied Thematic Analysis year: 2012 ident: 334_CR30 doi: 10.4135/9781483384436 – volume: 14 start-page: 58 issue: 1 year: 2019 ident: 334_CR27 publication-title: Implement Sci. doi: 10.1186/s13012-019-0898-y – volume: 6 start-page: 42 year: 2011 ident: 334_CR38 publication-title: Implement Sci. doi: 10.1186/1748-5908-6-42 – volume: 2 start-page: e190703 issue: 3 year: 2019 ident: 334_CR4 publication-title: JAMA Netw Open. doi: 10.1001/jamanetworkopen.2019.0703 – volume: 15 start-page: 56 issue: 1 year: 2020 ident: 334_CR29 publication-title: Implement Sci. doi: 10.1186/s13012-020-01021-y – volume: 8 start-page: 134 year: 2020 ident: 334_CR26 publication-title: Front Public Health doi: 10.3389/fpubh.2020.00134 – volume: 3 start-page: 32 year: 2015 ident: 334_CR13 publication-title: BMC Psychol. doi: 10.1186/s40359-015-0089-9 – volume: 10 start-page: 21 year: 2015 ident: 334_CR23 publication-title: Implement Sci. doi: 10.1186/s13012-015-0209-1 – volume: 10 start-page: e033208 issue: 2 year: 2020 ident: 334_CR24 publication-title: BMJ Open. doi: 10.1136/bmjopen-2019-033208 – volume: 11 start-page: 1451 issue: 8 year: 2021 ident: 334_CR33 publication-title: Diagnostics (Basel). doi: 10.3390/diagnostics11081451 – volume: 6 start-page: 102 year: 2018 ident: 334_CR28 publication-title: Front Public Health. doi: 10.3389/fpubh.2018.00102 – volume: 128 start-page: 90 issue: 2 year: 2010 ident: 334_CR3 publication-title: Sao Paulo Med J. doi: 10.1590/S1516-31802010000200009 – volume: 227 start-page: 31 year: 2020 ident: 334_CR7 publication-title: Am Heart J. doi: 10.1016/j.ahj.2020.06.003 – volume: 77 start-page: 772 issue: 6 year: 2021 ident: 334_CR10 publication-title: J Am Coll Cardiol. doi: 10.1016/j.jacc.2020.11.022 – volume: 52 start-page: 235 issue: 3 year: 2014 ident: 334_CR31 publication-title: Med Care. doi: 10.1097/MLR.0000000000000077 – volume: 11 start-page: 6 issue: 1 year: 2021 ident: 334_CR34 publication-title: Ann Intensive Care. doi: 10.1186/s13613-020-00799-w – volume: 106 start-page: 1934 issue: 24 year: 2020 ident: 334_CR6 publication-title: Heart. doi: 10.1136/heartjnl-2019-316429 – volume: 16 start-page: 36 issue: 1 year: 2021 ident: 334_CR37 publication-title: Implement Sci. doi: 10.1186/s13012-021-01105-3 – volume: 57 start-page: 2001519 issue: 3 year: 2021 ident: 334_CR11 publication-title: Eur Respir J. doi: 10.1183/13993003.01519-2020 – volume: 2 start-page: e12575 issue: 6 year: 2021 ident: 334_CR35 publication-title: J Am Coll Emerg Physicians Open. doi: 10.1002/emp2.12575 – volume: 34 start-page: 1032 issue: 6 year: 2019 ident: 334_CR20 publication-title: J Gen Intern Med doi: 10.1007/s11606-018-4818-7 – ident: 334_CR21 – volume: 133 start-page: 1019 issue: 9 year: 2020 ident: 334_CR12 publication-title: Am J Med. doi: 10.1016/j.amjmed.2020.03.041 – volume: 12 start-page: 447 issue: 5 year: 2014 ident: 334_CR15 publication-title: Ann Fam Med. doi: 10.1370/afm.1688 – volume: 33 start-page: mzab106 issue: 3 year: 2021 ident: 334_CR39 publication-title: Int J Qual Health Care. doi: 10.1093/intqhc/mzab106 – volume: 38 start-page: 655 issue: 3 year: 2016 ident: 334_CR40 publication-title: Int J Clin Pharm. – volume: 2 start-page: 10 issue: 1 year: 2013 ident: 334_CR16 publication-title: Clin Transl Med. doi: 10.1186/2001-1326-2-10 – volume: 12 start-page: 661 issue: 6 year: 2020 ident: 334_CR1 publication-title: J Grad Med Educ. doi: 10.4300/JGME-D-20-00216.1 – volume: 23 start-page: 290 issue: 4 year: 2014 ident: 334_CR41 publication-title: BMJ Qual Saf. doi: 10.1136/bmjqs-2013-001862 – volume: 21 start-page: 1605 issue: 12 year: 2019 ident: 334_CR8 publication-title: Eur J Heart Fail. doi: 10.1002/ejhf.1604 – volume: 10 start-page: e0130066 issue: 6 year: 2015 ident: 334_CR2 publication-title: PLoS One. doi: 10.1371/journal.pone.0130066 – volume: 9 start-page: 165 year: 2014 ident: 334_CR32 publication-title: Implement Sci. doi: 10.1186/s13012-014-0165-1 – volume: 11 start-page: 1172 issue: 7 year: 2021 ident: 334_CR25 publication-title: Diagnostics. doi: 10.3390/diagnostics11071172 – volume: 2 start-page: 107 issue: 2 year: 2022 ident: 334_CR14 publication-title: Glob Implement Res Appl. doi: 10.1007/s43477-022-00045-4 – volume: 38 start-page: 577 issue: 4 year: 2012 ident: 334_CR22 publication-title: Intensive Care Med. doi: 10.1007/s00134-012-2513-4 – volume: 6 start-page: 71 year: 2018 ident: 334_CR19 publication-title: Front Public Health doi: 10.3389/fpubh.2018.00071 – volume: 10 start-page: 4818 issue: 21 year: 2021 ident: 334_CR36 publication-title: J Clin Med. doi: 10.3390/jcm10214818 – volume: 174 start-page: 985 issue: 7 year: 2021 ident: 334_CR9 publication-title: Ann Intern Med. doi: 10.7326/M20-7844 |
| SSID | ssj0002511404 |
| Score | 2.2860012 |
| Snippet | Background
Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by... Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by multiple... BackgroundLung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea caused by... Abstract Background Lung ultrasound (LUS) is a clinician-performed evidence-based imaging modality that has multiple advantages in the evaluation of dyspnea... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 89 |
| SubjectTerms | Archives & records Clinical decision making COVID-19 Data collection Disease transmission Feedback Health Administration Health Policy Health Promotion and Disease Prevention Health Services Research Hospitalists Hospitals Implementation science Intervention Lung ultrasound Medicine Medicine & Public Health Pandemics Patients Pilot projects Public Health RE-AIM Ultrasonic imaging |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQxQEJId4EChokbmB143Vim1sprVgJCkIV6s2KHUcbaZtU3SzqD-EHM-M86PK8cE0m1sgzY38Tj79h7EUwSmjcuHiWFTmXvvIcJUsufGFEkCrIELuWvFfHx_r01Hy60uqLasJ6euB-4va8xlXczfMcUzWZlhVmCC4tUzeTSnrhI88nop4ryRStwQSc5UyOt2R0vrcmbivNqXid-pdJfrm1E0XC_t-hzF-LJX86MY0b0dFtdmtAkLDfa36HXQvNXXaz__0G_a2ie-xbLAWAReRMxgUNPh_y_cUH6FoIzZIsDcuhYwjaGYqyjUsHtBWsMPxhs0It1tRyCeoGECTC2VQnQ0IDHesa6D8uHHz8snjLU_Maigbqs7EkPY54Xq_aDiKL7X12cnR4cvCODw0YuM9nquNGFpjDoskyE3Sh06pydLOW9vhy5omHRmIAl2nunPPCODWXTrm80pVwxvn5A7bTtE14xKBSmfBEbVcgAMsrg6MZ5aXRDvMfBF0JS0dbWD-Qk1OPjJWNSYrObW8_i_az0X72MmEvp2_Oe2qOv0q_IRNPkkSrHR-gs9nB2ey_nC1hu6OD2CHW11ZoxNSCSH8S9nx6jVFKRy9FE9oNyijK_XA4nbCHvT9NmsypARKi0oSpLU_bUnX7TVMvIxO4oUNXkSXs1eiTP9T681Q8_h9T8YTdEDGYNE_FLtvpLjbhKbvuv3b1-uJZjMbvOxs4OA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLWg4wEJ8T0IDGQk3sBa4zqxzQvaRicqQZmmCe0tip2ERuqS0qRoP4QfzL2Ok6l87IXXxrXs5Pj63Ovrcwl5nWvJFWxcLIrSmAlbWAYtM8ZtqnkuZC5yV7Xkk5zP1fm5PvEBt8anVfY20RnqrLYYI9_nCpgLR2mV96vvDKtG4emqL6Fxk-ygUpkYkZ3D6fzkdIiyIIEWY9HfllHxfoMaV4phEjvWMRPscmtHcsL9f2ObfyZN_nZy6jak43v_O5X75K6novSgw84DciOvHpI7XRyPdteTHpGfLqeAzpz4MlhGejplB7PPtK1pXi0QMnThS48AYGia1c4G0bqgS7AjdLOEaTRYu4mWFQW2SS-GhBts5HVdG4oBYXr05evsAwv1O5pWtLzoc9tdj6tyWbfUyeE-JmfH07Ojj8xXcmA2HsuWaZGCMwzfPtK5SlVYFAav6CJZyMYWBW0EWIIsjI0xlmsjJ8JIExeq4EYbO9klo6qu8qeEFjLiFjXyUmBycaGhNy2t0MqAIwXsLSBh_zET61XOsdjGMnHejoqTDgAJACBxAEguA_Jm-M-q0_i4tvUhYmRoifrc7od6_S3xyz2xCriHmcSxUkqEWQF-rQmz0IyFFJbbSUD2emgk3mg0yRUuAvJqeAzLHc9w0iqvN9BGohMJ3amAPOkAOYxkgpWUgN4GRG5BdWuo20-qcuEkxTWe3vIoIG97UF8N69-v4tn1s3hObnO3zhQL-R4ZtetN_oLcsj_aslm_9Ev1F8q8R4Q priority: 102 providerName: ProQuest |
| Title | Using Iterative RE-AIM to enhance hospitalist adoption of lung ultrasound in the management of patients with COVID-19: an implementation pilot study |
| URI | https://link.springer.com/article/10.1186/s43058-022-00334-x https://www.ncbi.nlm.nih.gov/pubmed/35962441 https://www.proquest.com/docview/2850728237 https://www.proquest.com/docview/2702178288 https://pubmed.ncbi.nlm.nih.gov/PMC9372925 https://doaj.org/article/c8eedb36688841df828b1d1b0474c2c3 |
| Volume | 3 |
| WOSCitedRecordID | wos001255614700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: DOA dateStart: 20200101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: M~E dateStart: 20200101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: 7X7 dateStart: 20200101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: BENPR dateStart: 20200101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: PIMPY dateStart: 20200101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 2662-2211 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002511404 issn: 2662-2211 databaseCode: RSV dateStart: 20201201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwED7BhhAS4mW8BUZlJL6BReM4sc23bXSiEi1VmabyKYqdhEbqkqlpET-EH8zZeUGFgQRfIjW5WK5zd37OPj8H8DJTgkmcuGgYJhHlJjcUJVPKTKJYxkXGM1e15IOYTuVioWbtobC6y3bvtiSdp3ZmLaM3tSWnktRmn9sCZJwictzH6U5ac5x_Ou9XVixo5kPenZC58tWdWciR9V-FMH9PlPxlt9RNQqd3_6_79-BOCzrJUaMl9-FaVh7AzUm7rX4At5vFO9KcSXoA310iARk7xmV0h2Q-okfjCdlUJCuXVk_Isq03glpCkrRyjodUOVmh8yDbFf6P2hZsIkVJEGKSiz7Lxgq1ZK41savA5OTj-fgd9dVbkpSkuOgS2l2Ll8Wq2hDHgfsQzk5HZyfvaVu-gZpoKDZU8QQjYPzgocpkIv081_ZcrkUI6dBYFhuO5p_6kdbaMKVFwLXQUS5zppU2wSPYK6syewIkFyEzlhgvQfgW5QpbU8JwJTVGTwjZPPC7rxmbltrcVthYxS7EkVHcjH6Mox-70Y-_efCqf-eyIfb4q_SxVZJe0pJyuxvV-kvc2nhsJAIOHUSRlJL7aY7BrPZTXw-54IaZwIPDTsXi1lPUMZOIyJmlDPLgRf8Ybdxu3CRlVm1RRtjIEZuTHjxuNLLvSWDLJyGm9UDs6OpOV3eflMXS8Ygru2XLQg9edxr7s1t_Hoqn_yb-DG4xp_SS-uwQ9jbrbfYcbpivm6JeD-C6WAh3lQPYPx5NZ_OBWxbBX7PxZPZ54Gz7B3XpRkU |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQAIJcb8EBhgJnsBa47qxjYTQ2EWr1hWEpqlvVuwktFKXlKaF8T_4G_xHznEuU7nsbQ-8Jq7luN_5fI59_B1CXqRacgULF-v14ogJlzkGLRPGXax5KmQqUl-1ZCCHQzUa6Y9r5GdzFwbTKhtO9ESdFA73yDe5As-Fo7TKu9kXhlWj8HS1KaFRweIg_f4NQrbybX8H_t-XnO_tHm3vs7qqAHNRRy6YFjEEZjCOnk5VrMIss3hdFBeupONQXEUAKpMwstY6rq3sCittlKmMW21dF7q9RC4DjUvMIJMj2W7poLcuOqK5mqOizRIFtRTDjHksmibY6cry56sE_M21_TND87djWr_67d38z-btFrlRu9l0q7KL22Qtze-Q69UeJa2uXt0lP3y-BO17YWlgffppl231D-mioGk-RnOg47qsChgDjZPC8ystMjoFjqTLKcxaiXWp6CSn4EnTkzaZCBvVmrUlxc1uuv3huL_DQv2GxjmdnDR5-77H2WRaLKiX-r1Hji5iXu6T9bzI04eEZrLHHer_xeClRpmG3rR0QisLQSJ4pgEJG-wYVyu4YyGRqfGRnIpMhTcDeDMeb-Y0IK_a38wq_ZJzW79HSLYtUXvcPyjmn01NZcYp8KtsN4qUUiJMMojZbZiEtiOkcNx1A7LRINHUhFiaMxgG5Hn7GqgMz6fiPC2W0EZigAzdqYA8qPDfjqSLVaLAdQ-IXLGMlaGuvsknYy-XrvFkmvcC8rqxobNh_XsqHp3_Fc_I1f2jw4EZ9IcHj8k17k1csZBvkPXFfJk-IVfc18WknD_1HEGJuWDb-gVNW6FB |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGhhAS4n4JDDASPIHVxnUTGwmhsa4i2oUKTdN4smInoZW6pDQtjP_Bn-HfcY5zmcplb3vgNTm1HPd852Iff4eQ56kKuQTHxfr9OGDCZpaBZMK4jRVPRZiK1HUt2QsPDuTxsRqtkZ_NXRgsq2xsojPUSWFxj7zDJUQuHKlVOlldFjEaDN_OvjDsIIUnrU07jUpFdtPv3yB9K99EA_ivX3A-3Dncfs_qDgPMBt1wwZSIIUmDOfVVKmPpZ5nBq6PoxJKuRaIVARqa-IExxnJlwp4woQkymXGjjO3BsJfIBkTkAiC2MYr2R5_aDR6M3UVXNBd1ZNApkV5LMqyfxxZqgp2uOEPXM-Bvge6f9Zq_Hdo6Xzi88R-v4k1yvQ7A6VaFmFtkLc1vk2vV7iWtLmXdIT9cJQWNHOU0-AP6cYdtRft0UdA0HyNQ6LhuuAIwoXFSOMtLi4xOwXrS5RRWsMSOVXSSU4ix6UlbZoRCNZttSXEbnG5_OIoGzFevaZzTyUlT0e9GnE2mxYI6EuC75PAi1uUeWc-LPH1AaBb2uUVmwBji1yBTMJoKrVDSQPoIMatH_EaPtK253bHFyFS7HE8GutI9Dbqnne7pU4-8bH8zq5hNzpV-h-rZSiIruXtQzD_r2shpKyHiMr0gkFIKP8kgmzd-4psuAMRy2_PIZqOVujaVpT5TSY88a1-DkcOTqzhPiyXIhJg6w3DSI_crLLQz6WH_KAjqPRKuoGRlqqtv8snYEakrPLPmfY-8avB0Nq1_L8XD87_iKbkCkNJ70cHuI3KVO7RL5vNNsr6YL9PH5LL9upiU8ye1waBEXzC4fgEJNKuQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+Iterative+RE-AIM+to+enhance+hospitalist+adoption+of+lung+ultrasound+in+the+management+of+patients+with+COVID-19%3A+an+implementation+pilot+study&rft.jtitle=Implementation+science+communications&rft.au=Maw%2C+Anna+M&rft.au=Morris%2C+Megan+A&rft.au=Glasgow%2C+Russell+E&rft.au=Barnard%2C+Juliana&rft.date=2022-08-12&rft.issn=2662-2211&rft.eissn=2662-2211&rft.volume=3&rft.issue=1&rft.spage=89&rft_id=info:doi/10.1186%2Fs43058-022-00334-x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2662-2211&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2662-2211&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2662-2211&client=summon |